On the recordAugust 2, 2017
I come to the floor today to voice my support for the FDA Reauthorization Act. Within this legislation is a very important measure that will support the development of innovative and promising cancer drugs--the RACE for Children Act, which is a law that I introduced with Senator Michael Bennet of the State of Colorado. RACE for Children is sorely needed, as it would close a loophole that exists in current Federal law and prompt companies--pharmaceutical companies--to examine the safety and the efficacy of powerful cancer drugs and how they work on children. This, in turn, will provide doctors with the necessary information to properly treat children battling cancer. Pediatric cancer is a leading cause of death by disease among children. A startling statistic: One in every 285 children is diagnosed with cancer before the age of 20. While the good news is that researchers are continuing to make significant advances to treat and cure cancer for adults, the progress to develop safe drugs for pediatric cancer sadly lags far behind. One of the problems is that current law, the way it is today, directs pharmaceutical companies to study the safety and the efficacy of adult drugs on children.…
Source
govinfo.gov




